Three Gut Bacteria Spread Autoimmunity Between Mice With No Antibiotics Needed

Anyone who has spent time trying to trace an unexplained health issue back to their gut knows how murky the science can feel: a lot of correlation, not much mechanism. A new mouse study published in Nature Immunology in July 2026 is unusual because it supplies both. Researchers at Institut Pasteur, working with immunologists at the US National Institutes of Health, identified the specific immune cell that converts an imbalanced gut microbiome into body-wide autoimmune warning signs, and then showed that the underlying bacterial imbalance itself can spread from one mouse to another sharing a cage, with no antibiotics involved. It will not tell you whether your own gut is behind your symptoms, but it does show, in unusually concrete terms, how that kind of chain reaction could work.

AXL-Positive Dendritic Cells Convert Gut Imbalance Into Autoimmunity

The study, led by Gorana Cvijetic and colleagues including senior author Rejane Tussiwand, identifies AXL+inf-DC3 (an inflammatory subtype of type 3 dendritic cell marked by the protein AXL; dendritic cells are immune sentinels that sample the gut and instruct the rest of the immune system how to respond) as the cell type that turns gut bacterial imbalance into systemic autoimmune features. The team engineered mice that lack the gene Notch2 specifically in dendritic cells (called Notch2cKO mice). Losing Notch2 blocked a normal, tolerance-promoting dendritic cell subset called cDC2a from developing properly. In its place, the inflammatory AXL+inf-DC3 subset expanded dramatically, eventually accounting for roughly one third of all dendritic cells in the spleen and gut tissue of these mice. Notably, the tolerogenic dendritic cells that normally help keep the immune system calm (identified by the marker Rorc) were left untouched in number, meaning this was not a general immune breakdown but a specific shift toward one inflammatory cell type.

Why This Matters for Anyone Researching Autoimmune Symptoms

The mice with expanded AXL+inf-DC3 developed a cluster of findings that read like early lupus: elevated IgG1, IgG2b, IgG2c and IgA antibodies, immune complexes deposited in the kidneys by 16 weeks of age, tertiary lymphoid structures (small, disorganized immune hubs that form in inflamed tissue), and increased antibody-producing plasma cells across the spleen and lymph nodes. The researchers also found that one of the most strongly downregulated genes in the affected dendritic cells was Dnase1l3, the same gene whose loss causes early-onset, high-penetrance lupus in humans, independent of this study. That overlap is circumstantial, not proof the two conditions share a cause, but it is the kind of detail that gives the mouse model more relevance to human autoimmune disease than a typical inflammation study. More broadly, gut dysbiosis has separately been linked to systemic autoimmune disease in humans, which is the backdrop this study is trying to explain mechanistically.

How Researchers Proved the Bacteria, Not Just the Gene, Were Driving It

What sets this study apart methodologically is that the researchers didn't stop at showing sick mice have both dysbiosis and autoimmune features side by side, they tested whether the dysbiosis alone was sufficient to cause the autoimmune features in genetically normal mice. They tried three separate transfer routes: co-housing four healthy wild-type mice with one Notch2cKO or control mouse, switching cages, and directly gavaging healthy mice with fecal material from cKO donors. Critically, no antibiotics were used to clear out the recipients' existing gut bacteria first, which is the standard shortcut in this kind of experiment and one that makes a result easier to achieve but harder to generalize. All three routes worked: healthy mice developed the same elevated IgA, IgG2b and IgG2c antibody pattern as the donor mice. Weekly gut sequencing over 21 days identified three bacteria that consistently tracked with the phenotype as it spread: Parasutterella, Mucispirillum, and Chlamydia (specifically Chlamydia muridarum, a species that infects rodents, not the human sexually transmitted pathogen). These three colonized the recipient mice within 7 days, and antibody levels began rising from around day 14 onward. At the same time, Akkermansia muciniphila, a bacterium generally associated with a healthy gut lining, was rapidly depleted from the recipients' gut communities. The researchers also ran a bidirectional genetic test: mice with fewer AXL+inf-DC3 cells at baseline (Ccr2 knockouts) developed a delayed, weaker antibody response after exposure to the same diluted feces, while mice with more of these cells at baseline (Flt3l knockouts) developed a faster, stronger one. That dose-response relationship, in both directions, is what elevates AXL+inf-DC3 from a cell type that merely correlates with autoimmunity to one that appears to actively drive it.

What This Does, and Does Not, Mean If You're Researching Your Own Gut Health

If you are looking at this because you suspect a health issue traces back to your gut, the honest translation is: this study describes a plausible biological pathway, not a diagnosis or a treatment. Everything here happened in mice, and there is currently no evidence that the same three bacteria, or even the same AXL+inf-DC3 cell type, play an identical role in the human gut. What is worth knowing is the general shape of the mechanism: an imbalance in specific gut bacteria promoted expansion of one inflammatory immune cell type, which in turn drove antibody production and immune complex deposition in the kidneys, a pattern that shows up in autoimmune conditions like lupus. If you already have a diagnosed autoimmune condition and unexplained flares, this is a reasonable thing to mention to a doctor as background context, not a reason to seek out a microbiome test or start a supplement regimen aimed at any of the specific bacteria named here. Nothing in this study establishes that manipulating gut bacteria in humans changes autoimmune outcomes.

The Limits of a Mouse-Only, Single-Colony Finding

Several caveats matter here. First, what the paper calls "preclinical autoimmunity" is elevated autoantibodies and kidney immune complexes, not lupus itself or any diagnosed autoimmune disease; the mice were not observed to develop overt clinical illness. Second, the three-bacteria signature came from a dysbiosis that arose spontaneously in one mouse colony, and it includes Chlamydia muridarum, a bacterium specific to rodent facilities, so it is unclear whether this exact combination would show up, or matter, in a different colony or in humans. Third, the gut sequencing that identified the three culprit species rested on only three mice per group, a small sample for that particular analysis even though other parts of the study used far larger, replicated cohorts. Fourth, the two knockout strains used in the bidirectional dose-response test (Ccr2 and Flt3l) lack their target genes throughout the whole body, not just in AXL+inf-DC3 cells, so the results are consistent with this cell type driving the effect but do not prove it in isolation. Finally, the three bacteria were never tested individually, no one colonized germ-free mice with just one species at a time to see which of the three actually matters, so it remains possible that only one or two of the trio is doing the real work. It is also worth noting plainly: this study was funded by Institut Pasteur and the NIH's intramural research program, with no indication of commercial involvement, though the paper's competing-interests statement was not available for review here.

What Comes Next

The obvious next step is deconvolving the three-bacteria trio, colonizing germ-free mice with each species alone to find out which one, or which combination, is necessary and sufficient. Beyond that, the more consequential open question is whether AXL+inf-DC3, or an equivalent inflammatory dendritic cell subset, exists and behaves the same way in the human gut, which would require looking at tissue from people with autoimmune conditions rather than mice. Until that work is done, this remains a mechanistic roadmap in an animal model, a genuinely detailed one, but not yet a finding with direct clinical application.

Common Questions

Does this mean autoimmune diseases are contagious? Not in the way that phrase usually implies. What spread between mice was a bacterial imbalance and its downstream immune effects, transmitted through shared living space or direct fecal transfer, not an infection with a single pathogen. There is no evidence this applies to humans living together.

What is a dendritic cell, and why does this one matter? Dendritic cells are immune cells that sample the gut environment and tell the rest of the immune system how to respond to what they find. The AXL+inf-DC3 subtype identified here appears to misread a bacterial imbalance as a threat and trigger an inflammatory, antibody-producing response instead of tolerance.

Could probiotics or a specific diet fix this? Nothing in this study tested that, and the researchers make no such claim. The study establishes a mechanism in mice, not a validated human intervention.

Is this the same as lupus? No. The mice developed some lupus-associated features, elevated antibodies and kidney immune complex deposits, but the paper explicitly describes this as preclinical autoimmunity, not a lupus diagnosis or overt disease.

References

1. Cvijetic G, Ottaviani V, Conway IO, et al. (2026). Dysbiosis-induced expansion of AXL-positive inflammatory type 3 dendritic cells triggers preclinical autoimmunity. Nature Immunology. https://doi.org/10.1038/s41590-026-02599-z
2. Walaa K. Mousa, Fadia Chehadeh, Shannon Husband (2022). Microbial dysbiosis in the gut drives systemic autoimmune diseases. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2022.906258
3. Ezinne Aja, Amber Zeng, Weston Gray, Kaden Connelley, Anil Chaganti, Jonathan P. Jacobs (2025). Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila. Nutrients. https://doi.org/10.3390/nu17030562